Periodic Reporting for period 4 - IMMUcan (Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts)

Immune checkpoint inhibitors have shown promising results in some cancer types, but biomarkers to select patients that might respond to the treatment still need to be established. Similarly, rationale for combining immune checkpoint inhibitors with conventional therapy...